Evogene
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $884 | $2,444 | $1,611 | $1,796 |
Gross Profit | 748 | 830 | 856 | 715 |
EBITDA | -2,610 | -1,946 | -2,540 | -4,681 |
EBIT | -2,900 | -2,525 | -3,133 | -5,308 |
Net Income | -4,462 | -2,587 | 427 | -7,630 |
Net Change In Cash | 884 | 2,444 | 1,611 | 1,796 |
Free Cash Flow | -2,303 | -5,304 | -5,529 | -5,060 |
Cash | 8,329 | 7,495 | 15,301 | 11,317 |
Basic Shares | 7,225 | 6,798 | 6,795 | 5,807 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $8,511 | $5,640 | $1,675 | $930 |
Gross Profit | 5,828 | 1,399 | 766 | 163 |
EBITDA | -15,478 | -23,204 | -26,933 | -27,795 |
EBIT | -17,982 | -25,816 | -29,513 | -30,029 |
Net Income | -16,485 | -23,879 | -26,638 | -27,793 |
Net Change In Cash | 8,511 | 5,640 | 1,675 | 930 |
Free Cash Flow | -20,326 | -22,362 | -24,849 | -25,563 |
Cash | 15,301 | 20,772 | 28,980 | 32,325 |
Basic Shares | 5,697 | 4,568 | 4,121 | 41,013 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.85 |
2025-03-31 | -$0.38 |
2024-12-31 | $0.06 |
